|
 |
| home > ict > Winter 2006 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT |
 |
| |
|
|
In her Editor’s Letter, Pamela Barnacal peruses the latest offerings in the closing issue of 2006
|
|
|
|
| Why is the implementation of rigorous cognition assessments in clinical trials so important? In Know Your Trials, Mark Ware and Jennifer Lewis of Cognitive Drug Research explore the progression of cognitive research in drug development to the present day and beyond, reiterating the importance of using the best instruments available |
|
|
| The corporate strategy for recruitment is coming of age. With commentators calling for the introduction of a clear vision for clinical studies, David J Cocker of Goldwood assesses the impact of current environmental factors on the core challenge of recruiting volunteers, in Recruitment on Trial |
|
|
| As the mass of data accrued through patient safety assessments swells wildly, establishing a programme for the 21st century is paramount. In A Lab with a View, Alan Craig of ACM-Pivotal Laboratories puts the case for the professional clinical laboratory to strengthen the systems, test selection and analyses of clinical studies |
|
|
|
| In the light of a recent, extensive review of the PASS guidelines, Martin Knight of Covance Late Stage Development Services examines the proposed changes and clarifications that must be considered when designing a pharmacovigilance programme, in A PASS Through the Drug Safety Range |
|
|
| The media storm surrounding the testing of monoclonal antibody TGN1412, and its subsequent effects on six volunteers, appears to have caused untold damage for clinical trial recruiters. In Trials and Tabloid Headlines, Alison Dennis of Reed Smith reviews the regulatory changes needed to protect patients - and in turn rebuild public confidence - following the traumatic turn of events at Northwick Park earlier this year |
|
|
|
| The prospect of tightening budgets and limited resources have forced pharmaceutical companies to re-evaluate their stance on outsourcing. Never has the time for collaboration between vendors and sponsors been so productive, nor so crucial, reports i3 Statprobe's Gregg Dearhammer as he unravels In and Outsourcing: Pharma's Evolutionary Side |
|
|
| Eastern Europe is now the second highest patient recruiting region in the world for industry-sponsored clinical trials. Richard Leach of RCT Global, LLC, investigates a compelling story of rapid growth, in A Home for Trials: the Bloc Reborn |
|
|
|
| Reducing the data entry backlog that typically follows paper diary studies may sound like a feat worthy of a magician, but the time to final analysis can indeed be shortened, asserts Symfo Inc's Judy Woods, as she begins the process of Demystifying e-Diaries |
|
|
| Rarely seen in clinical trials, IT governance frameworks like the Common Objectives for Information and related Technology (COBITTM), provide a much-needed end-to-end perspective; Dr Carsten Heil of Viasys Healthcare GmbH watches CDM on the Move |
|
|
| In SDTM and the Clinical Information Life Cycle, David Evans of Octagon Research Solutions Inc examines the FDA's preferred language for clinical information - vital to success in the collection, processing and submission of clinical research information |
|
|
|
| What are the objectives of EC guidelines such as Good Distribution Practice? In Ship-Shape Trials, the MHRA's John Taylor suggests how to avoid hazards when handling goods and ensure the shipping of clinical trial materials enjoys a smooth passage |
|
|
| No Transit, No Trial - this is the straightforward message from Eric Raemdonck of IATA, who delivers details on a Perishable Cargo Manual produced to promote prompt, stress-free transportation for clinical studies |
|
|
| Pharmaceutical products are being launched in an increasingly crowded market to ever more sophisticated consumers. Impressed by blister pack wallets, which offer patients a variety of applications, Raupack's Alan Holmes asks, What's In Your Wallet? |
|
|
|
| Feel in the dark when it comes to clinical data management? Put a date in your diary for March 2007 and get to grips with integration across the clinical trial continuum, as DIA CDM Meeting Celebrates its 22nd Year |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
Exploratory Clinical Development World Americas 2008
23-25 September 2008, Philadelphia Marriott Downtown, 1201 Market Street, Philadelphia, Pennsylvania, 19107 USA
Following on from the huge success of the Exploratory
Clinical Development World Europe, the Americas
congress will give you a critical insight into the latest strategies on how the
industry is addressing and elevating the current challenges in early clinical
development.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
__________________________
__________________________
__________________________
__________________________
|
